ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,915Medicare Part D Prescriptions Filled, Including Refills

Rank: 204 out of 1692

$459K Total Retail Price of All Prescriptions

Rank: 293 out of 1692

375 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 375 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 375 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 6,199 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 587 301 S3 1 6
SIMVASTATIN 544 356 2 1
OMEPRAZOLE 323 215 3 5
FUROSEMIDE 310 252 4 7
LISINOPRIL 284 184 5 2
HYDROCHLOROTHIAZIDE 218 147 6 9
NEXIUM 199 124 7 25
ZOLPIDEM TARTRATE 183 60 8 23
LEVOTHYROXINE SODIUM 180 125 9 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 176 100 10 19
TRAMADOL HCL 171 96 11 16
AMLODIPINE BESYLATE 164 142 12 3
METOPROLOL TARTRATE 153 127 13 10
TIZANIDINE HCL 150 65 14 127
METFORMIN HCL 141 86 15 8
METOPROLOL SUCCINATE 120 103 16 18
MELOXICAM 118 70 17 41
CARVEDILOL 113 84 18 24
GABAPENTIN 108 47 19 13
SERTRALINE HCL 98 54 20 22
BENAZEPRIL HCL 94 89 21 69
CITALOPRAM HBR 94 73 21 21
METFORMIN HCL ER 94 56 21 49
PANTOPRAZOLE SODIUM 90 57 24 39
WARFARIN SODIUM 84 61 25 14
TAMSULOSIN HCL 83 46 26 31
POTASSIUM CHLORIDE 82 64 27 20
PRAVASTATIN SODIUM 81 55 28 12
FLUOXETINE HCL 79 59 29 52
VERAPAMIL ER 78 52 30 90
ATENOLOL 78 69 30 15
TRAZODONE HCL 72 18 32 33
LYRICA 70 16 33 111
PROMETHAZINE HCL 69 15 R 34 81
CYMBALTA 66 24 35 51
RAMIPRIL 65 51 36 108
GLIPIZIDE ER 65 60 36 87
BISOPROLOL-HYDROCHLOROTHIAZIDE 65 49 36 118
GEMFIBROZIL 64 29 39 98
RANITIDINE HCL 64 48 39 28
CLOPIDOGREL 63 45 41 43
SYNTHROID 63 50 41 59
DIOVAN 61 46 43 42
ROPINIROLE HCL 59 39 44 101
CRESTOR 59 25 44 26
AMLODIPINE BESYLATE-BENAZEPRIL 59 59 44 67
SINGULAIR 58 23 47 79
ATORVASTATIN CALCIUM 57 44 48 11
VENLAFAXINE HCL ER 56 0 49 84
BUPROPION HCL SR 52 24 50 171
NAPROXEN 50 44 51 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 15, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.